Advertisement

Hernia

pp 1–7 | Cite as

Selective muscle botulinum toxin A component paralysis in complex ventral hernia repair

  • K. E. Elstner
  • J. W. Read
  • J. Saunders
  • P. H. Cosman
  • O. Rodriguez-Acevedo
  • A. S. W. Jacombs
  • R. T. Martins
  • N. IbrahimEmail author
Original Article

Abstract

Introduction

Repair of complex ventral hernia presents a significant challenge plagued by high morbidity and recurrence. Recent studies have demonstrated significant benefits achievable with preoperative Botulinum Toxin A (BTA) chemical component paralysis to the abdominal wall muscles, facilitating primary closure of complex ventral hernia defects. However, transversus abdominis is known to play an integral role in truncal stability, and its paralysis can result in unwanted physiological changes. This is the first study to report on selective administration of preoperative BTA to internal and external oblique muscles only, thus sparing transversus abdominis from paralysis.

Methods

This is a prospective observational study of 46 patients who underwent either selective two-layer or standard three-layer abdominal wall muscle BTA injection prior to elective laparoscopic ventral hernia repair. Serial abdominal CT imaging was performed to compare defect size and length of the lateral abdominal musculature.

Results

46 patients received preoperative BTA injections (23 in each group). A comparison of gains achieved from chemical component paralysis demonstrated no statistically significant difference between the two groups. Fascial closure was achieved in all cases, with no post-operative sequelae of abdominal hypertension. There are no hernia recurrences to date.

Conclusion

Preoperative selective muscle chemical component paralysis is an effective technique to counteract the chronic muscle retraction observed in large ventral hernias. Transversus abdominis plays a significant role in truncal and spinal stability, and sparing it from paralysis preserves an important component of abdominal wall physiology and does not detract from the ability to primarily close complex defects.

Keywords

Complex ventral hernia Incisional hernia Botulinum toxin A Chemical component paralysis 

Notes

Acknowledgements

A/Prof Michael Talbot, Dr William Mackie, Dr Alexander Bay, and Isabelle Ibrahim are acknowledged

Funding

There are no sources of funding to disclose.

Compliance with ethical standards

Conflicts of interest

All authors (KE, JS, PC, OR, AJ, RTM, and NI) declare no conflicts of interest, with the exception of JR, who declares conflict of interest related to the submitted work as he receives financial remuneration from Medicare as a radiologist.

Ethical approval

Approval from the institutional review board was not required for this study.

Human and animal rights

The study including human participants has been performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from all individual participants included in this study.

References

  1. 1.
    Weissler JM, Lanni MA, Tecce MG et al (2017) Chemical component separation: a systematic review and meta-analysis of botulinum toxin for management of ventral hernia. J Plast Surg Hand Surg 51:366–374CrossRefGoogle Scholar
  2. 2.
    Deerenberg EB, Timmermans L, Hogerzeil DP et al (2015) A systematic review of the surgical treatment of large incisional hernia. Hernia 19:89–101CrossRefGoogle Scholar
  3. 3.
    Flum DR, Horvath K, Koepsell T (2003) Have outcomes of incisional hernia repair improved with time? A population-based analysis. Ann Surg 237:129–135CrossRefGoogle Scholar
  4. 4.
    Heniford BT, Park A, Ramshaw BJ et al (2003) Laparoscopic repair of ventral hernias: nine years’ experience with 850 consecutive hernias. Ann Surg 238:391–399Google Scholar
  5. 5.
    Awad ZT, Puri V, LeBlanc K et al (2005) Mechanisms of ventral hernia recurrence after mesh repair and a new proposed classification. J Am Coll Surg 201:132–140CrossRefGoogle Scholar
  6. 6.
    Ramirez OM, Ruas E, Dellon AL (1990) “Components Separation” method for closure of abdominal-wall defects: an anatomic and clinical study. Plast Reconstr Surg 86:519–526CrossRefGoogle Scholar
  7. 7.
    Heller L, McNichols CH, Ramirez OM (2012) Component separations. Semin Plast Surg 26:25–28CrossRefGoogle Scholar
  8. 8.
    Jardim YJ, Mesquita GHA, Pipek LZ et al (2018) Chemical components separation with the use of botulinum toxin A: a critical review for correction of ventral hernia. J Abdom Wall Reconstr 1:1002Google Scholar
  9. 9.
    Zendejas B, Khasawneh MA, Srvantstyan B et al (2013) Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs. World J Surg 37:2830–2837CrossRefGoogle Scholar
  10. 10.
    Ibarra-Hurtado TR, Nuno-Guzman CM, Echeagaray-Herrera JE et al (2009) Use of botulinum toxin type A before abdominal wall hernia reconstruction. World J Surg 33:2553–2556CrossRefGoogle Scholar
  11. 11.
    Ibarra-Hurtado TR, Nuno-Guzman CM, Miranda-Diaz AG et al (2014) Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management. Hernia 18:647–652CrossRefGoogle Scholar
  12. 12.
    Zielinski MD, Goussous N, Schiller HJ et al (2013) Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen. Hernia 17:101–107CrossRefGoogle Scholar
  13. 13.
    Farooque F, Jacombs A, Roussos E et al (2016) Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair. ANZ J Surg 86:79–83CrossRefGoogle Scholar
  14. 14.
    Elstner KE, Jacombs AS, Read JW et al (2016) Laparoscopic repair of complex ventral hernia facilitated by pre-operative chemical component relaxation using Botulinum Toxin A. Hernia 20:209–219CrossRefGoogle Scholar
  15. 15.
    Elstner KE, Read JW, Rodriguez-Acevedo O (2017) Preoperative chemical component relaxation using Botulinum Toxin A: enabling laparoscopic repair of complex ventral hernia. Surg Endosc 31:761–768CrossRefGoogle Scholar
  16. 16.
    Rodriguez-Acevedo O, Elstner KE, Jacombs ASW et al (2018) Preoperative Botulinum Toxin A enabling defect closure and laparoscopic repair of complex ventral hernia defects. Surg Endosc 32:831–839CrossRefGoogle Scholar
  17. 17.
    Smoot D, Zielinski M, Jenkins D et al (2011) Botox A injection for pain after laparoscopic ventral hernia: a case report. Pain Medicine 12:1121–1123CrossRefGoogle Scholar
  18. 18.
    Rudmik LR, Schieman C, Dixon E et al (2006) Laparoscopic incisional hernia repair: a review of the literature. Hernia 10:110–119CrossRefGoogle Scholar
  19. 19.
    Heller L, Chike-Obi C, Xue AS (2012) Abdominal wall reconstruction with mesh and components separation. Semin Plast Surg 26:29–35CrossRefGoogle Scholar
  20. 20.
    Saulis AS, Dumanian GA (2002) Periumbilical rectus abdominis perforator preservation significantly reduces superficial wound complications in “separation of parts” hernia repairs. Plast Reconstr Surg 109:2275–2282CrossRefGoogle Scholar
  21. 21.
    Lowe JB, Garza JR, Bowman JL, Rohrich RJ, Strodel WE (2000) Endoscopically assisted “components separation” for closure of abdominal wall defects. Plast Reconstr Surg 105:720–729CrossRefGoogle Scholar
  22. 22.
    Maas SM, de Vries Reilingh TS, van Goor H, de Jong D, Bleichrodt RP (2002) Endoscopically assisted “components separation technique” for the repair of complicated ventral hernias. J Am Coll Surg 194:388–390CrossRefGoogle Scholar
  23. 23.
    Rosen MJ, Williams C, Kin J, McGee MF, Schomisch S, Marks J, Ponsky J (2007) Laparoscopic versus open-component separation: a comparative analysis in a porcine model. Am J Surg 194:385–389CrossRefGoogle Scholar
  24. 24.
    Dressler D (2012) Clinical applications of botulinum toxin. Curr Opin Microbiol 15:325–336CrossRefGoogle Scholar
  25. 25.
    Ganong W (1995) Review of medical physiology 17th Ed. Appleton and LangeGoogle Scholar
  26. 26.
    Haggmark T, Thorstensson A (1979) Fibre types in human abdominal muscles. Acta Physiol Scand 107:319–325CrossRefGoogle Scholar
  27. 27.
    Hodges PW (2003) Neuromechanical stiffness of the spine. Thesis Dissertation. Karolinska InstituteGoogle Scholar
  28. 28.
    Hodges PW, Richardson CA (1998) Delayed postural contraction of transversus abdominis in low back pain associated with movement of the lower limb. J Spinal Disord 11:46–56CrossRefGoogle Scholar
  29. 29.
    Hodges PW, Richardson CA (1996) Inefficient muscular stabilization of the lumbar spine associated with low back pain: a motor control evaluation of transversus abdominis. Spine 21:2640–2650CrossRefGoogle Scholar
  30. 30.
    McGill SM, Grenier S, Kavcic N, Cholewicki J (2003) Coordination of muscle activity to assure stability of the lumbar spine. J Electromyogr Kinesiol 13:353–359CrossRefGoogle Scholar
  31. 31.
    Hodges PW, Richardson CA (1997) Feedforward contraction of transversus abdominis is not influenced by the direction of arm movement. Exp Brain Res 114:362–370CrossRefGoogle Scholar

Copyright information

© Springer-Verlag France SAS, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Macquarie University Hospital, Technology PlaceMacquarieAustralia
  2. 2.Hernia Institute AustraliaEdgecliffAustralia
  3. 3.Macquarie Medical ImagingMacquarie University Hospital, Technology PlaceMacquarieAustralia
  4. 4.University of Notre DameSydneyAustralia

Personalised recommendations